News

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Pharmaceutical company Novo Nordisk is teaming up with direct-to ... or if the FDA-approved drug is not appropriate for a patient, such as in the case of an allergy. Although there had been ...